| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 145.12B | 143.61B | 148.72B | 156.05B | 146.48B | 135.74B |
| Gross Profit | 26.44B | 25.41B | 27.14B | 31.96B | 30.26B | 27.44B |
| EBITDA | 22.83B | 21.19B | 20.69B | 23.46B | 21.53B | 19.66B |
| Net Income | 9.44B | 8.00B | 7.54B | 9.33B | 8.94B | 7.25B |
Balance Sheet | ||||||
| Total Assets | 171.69B | 174.41B | 175.47B | 176.25B | 178.31B | 172.89B |
| Cash, Cash Equivalents and Short-Term Investments | 9.03B | 6.99B | 7.21B | 7.00B | 6.20B | 5.52B |
| Total Debt | 64.44B | 72.47B | 78.08B | 78.44B | 86.02B | 88.25B |
| Total Liabilities | 98.38B | 103.58B | 107.73B | 111.34B | 118.82B | 119.38B |
| Stockholders Equity | 72.50B | 70.16B | 66.73B | 64.22B | 58.99B | 53.11B |
Cash Flow | ||||||
| Free Cash Flow | 15.77B | 16.24B | 11.39B | 16.40B | 14.21B | 12.75B |
| Operating Cash Flow | 16.61B | 17.39B | 13.59B | 18.17B | 16.28B | 14.89B |
| Investing Cash Flow | -2.01B | -3.69B | -3.10B | -1.80B | -2.43B | -3.18B |
| Financing Cash Flow | -14.55B | -13.90B | -10.29B | -15.58B | -13.18B | -13.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥6.22B | 14.96 | ― | 3.96% | -2.24% | 3.22% | |
71 Outperform | ¥115.05B | 21.77 | 19.59% | 0.16% | 18.08% | 136.77% | |
69 Neutral | ¥299.89B | 14.55 | 30.73% | 2.20% | 4.52% | ― | |
69 Neutral | ¥2.40B | 9.54 | ― | ― | 28.85% | 58.77% | |
64 Neutral | ¥107.53B | 11.39 | ― | 4.17% | 0.44% | 44.52% | |
64 Neutral | ¥9.71B | 35.99 | ― | 3.65% | 16.07% | 50.91% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |